chlorpheniramine mal.2mg, ephedrine Hcl 8mg, codeine phosp. 8mg, NH4Cl 80mg/5mL
Opioid analgesic
What it is used for
Therapeutic use is agent- and indication-specific within the class (Opioid analgesic). Use according to culture results, national guidelines (Kenya STG/EML where applicable) and the current product SmPC. Cough suppressant (anti-tussive)
Warnings
[From component Chlorpheniramine] Warnings Ask a doctor before use if you have a breathing problem such as emphysema or chronic bronchitis glaucoma difficulty in urination due to enlargement of the prostate gland
Possible side effects
[From component Chlorpheniramine] Drowsiness; psychomotor impairment; anti-muscarinic effects [e.g. urinary retention; dry mouth; GI disturbances; blurred vision]; allergic reactions; epileptic form seizure in patients with cerebral cortex focal lesion; muscle weakness; tachycardia; tight chest; paradoxical CNS stimulation - mostly in children.
Storage
Store as labelled. Keep out of reach of children.
No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.